No Detail Found!

Clinical Efficacy Comparison of Saccharomyces Boulardii and Lactic Acid as Probiotics in Acute Pediatric Diarrhea.

Author(s)
Shakila Asmat Department of Pediatrics, Bolan Medical College, Quetta, Pakistan; Department of Pediatrics, Sheikh Zayed Hospital, Lahore, Pediatrics, Bolan Medical College, Quetta,
Fouzia Shaukat Department of Pediatrics, Sheikh Zayed Hospital, Lahore, Pediatrics, Bolan Medical College, Quetta,
Raheela Asmat Department of Pediatrics, Bolan Medical College, Quetta, Pediatrics, Bolan Medical College, Quetta,
Hafiz Faiq Siddique Gul Bakhat Department of Pediatrics, Bolan Medical College, Quetta, Pediatrics, Bolan Medical College, Quetta,
Tauseef M Asmat Department of Pediatrics, Bolan Medical College, Quetta, Pediatrics, Bolan Medical College, Quetta,
Abstract
Objective: To compare the efficacy of Saccharomyces boulardii and lactic acid producing probiotics in addition to usual treatment regimen to cure diarrhea among children (6 months to 5 years of age). Study Design: Randomized controlled trial. Place and Duration of Study: Department of Pediatrics, Sheikh Zayed Hospital, Lahore, from February to July 2015. Methodology: Children suffering from acute diarrhea were orally administered Saccharomyces boulardii and lactic acid producing probiotics for 5 days. The efficacy of administered probiotics was monitored. Patients were given Saccharomyces boulardii and lactic acid producing probiotics randomly to remove the bias. Results: Two hundred patients randomly selected for trials; out of which, 100 were treated with Saccharomyces boulardii while the other 100 were supplemented with lactic acid concomitantly along with conventional diarrhea treatment. Results indicated that Saccharomyces boulardii treatment group has significantly higher efficacy rate (45%) compared to lactic acid producing probiotics (26%). Conclusion: This study concluded that Saccharomyces boulardii has a better efficacy compared to lactic acid and may be adopted as a probiotic of choice.
Publication Details
Page(s) 214-217
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 3, Year: 2018

Request the full text from PASTIC

References
2001.The joint FAO/WHO expert consultation on evaluation of health and nutrition properties of probiotics in food held in Córdoba,Argentina from 1-4 October -
Kling J. Green, 2014.Tea and pomegranate extract help fight diarrhea in children,Medscape Medical News. Accessed: October 24 -
1995.The treatment of diarrhoea. A manual for physicians and other senior health workers, -
FarthingM,SalamMA,LindbergG,DiteP,KhalifI, 2013.Review team: Acute diarrhea in adults and children: a global perspective,J Clin Gastroenterol 47 12 -20
KawaharaT,MakizakiY,OikawaY,TanakaY,MaedaA,ShimakawaM, 2017.Oral administration of bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors,PloS One 12 e0173979 -
ParasharUD,JohnsonH,SteeleAD,TateJE, 2016.Health impact of rotavirus vaccination in developing countries: progress and way forward,Clin Infect Dis 62 S91 -5
YangB,XiaoL,LiuS,LiuX,LuoY,JiQ, 2017.Exploration of the effect of probiotics supplementation on intestinal microbiota of food allergic mice,Am J Transl Res 9 376 -85
SharifA,KashaniHH,NasriE., 2017.The role of probiotics in the treatment of dysentery: a randomized double-blind clinical trial,Probiotics Antimicrob Proteins 9 380 -5
Muhammad ZahidM,PfeilerEA,BrownJB, 2011.Regulation of induced colonic inflammation by lactobacillus acidophilus deficient in lipoteichoic acid,Proc Natl Acad Sci USA 108 4623 -
ErenM,DinleyiciEC,VandenplasY., 2010.Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: a randomized, controlled, open label study,Am J Trop Med Hyg 82 488 -90
LopetusoL,GrazianiC,GuarinoA,LamborghiniA,MasiS., 2017.Stanghellini gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea,Eur Rev Med Pharmacol Sci 21 873 -83
PozzoniP,RivaA,BellatorreAG, 2012.Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, doubleblind, placebo-controlled trial,Am J Gastroenterol 107 922 -31
FeizizadehS,Salehi-AbargoueiA,AkbariV, 2014.Efficacy and safety of saccharomyces boulardii for acute diarrhea,Pediatrics 134 176 -91
HemalathaR,OuwehandAC,SaarinenMT,PrasadUV,SwethaK,BhaskarV, 2017.Effect of probiotic supplementation on total lactobacilli, bifidobacteria and short chain fatty acids in 2-5-year-old children,Microb Ecol Health Dis 28 1298340 -
LiuZ,RoyNC,GuoY, 2016.Human breast milk and infant formulas differentially modify the intestinal microbiota in human infants and host physiology in rats,J Nutr 146 191 -9
BinZ,Ya-ZhengX,Zhao-HuiD,BoC,Li-RongJ,VandenplasY., 2015.The efficacy of saccharomyces boulardii CNCM I-745 in addition to standard helicobacter pylori eradication treatment in children,Pediatric gastroenterology, Hepatol Nutr 18 17 -22
StierH,BischoffSC, 2016.Influence of saccharomyces boulardii CNCM I-745on the gut-associated immune system,Clin Exp Gastroenterol 9 269 -79
FeizizadehS,Salehi-AbargoueiA,AkbariV, 2014.Efficacy and safety of saccharomyces boulardii for acute diarrhea,Pediatrics 134 e176 -91
MoréMI,SwidsinskiA, 2015.Saccharomyces boulardii CNCM i-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis‚ a review,Clin Exp Gastroenterol 8 237 -55
Pontier-BresR,MunroP,BoyerL, 2014.Saccharomyces boulardii modifies salmonella typhimurium traffic and host immune responses along the intestinal tract,PLoS One 9 e103069 -
0

Citations

0

Downloads

116

Views